ISDA

Deposition Date 2005-10-28

Release Date 2006-07-11

Last Version Date 2023-08-23

Entry Detail

PDB ID:

2EU2

Keywords:

LYASE

Title:

Human Carbonic Anhydrase II in complex with novel inhibitors

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli BL21

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.15 Å

R-Value Free:

0.16

R-Value Work:

0.13

R-Value Observed:

0.13

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Carbonic anhydrase 2
Gene (Uniprot):CA2
Chain IDs:A
Chain Length:260
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00918 Pfam ID:PF00194 EC:4.2.1.1

Ligand Molecules

5DS

Primary Citation

X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes.

Fisher, S.Z, Govindasamy, L, Boyle, N, Agbandje-McKenna, M, Silverman, D.N, Blackburn, G.M, McKenna, R.Show

Acta Crystallogr.,Sect.F 62 618 622 (2006)

PMID: 16820676 DOI: 10.1107/S1744309106020446

Abstact

Human carbonic anhydrases (CAs) are well studied targets for the development of inhibitors for pharmaceutical applications. The crystal structure of human CA II has been determined in complex with two CA inhibitors (CAIs) containing conventional sulfonamide and thiadiazole moieties separated by a -CF2- or -CHNH2- spacer group. The structures presented here reveal that these spacer groups allow novel binding modes for the thiadiazole moiety compared with conventional CAIs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures